Pancreatic Cancer Research

ResearcherUniversity of New MexicoNo recent work listed

Neda Hashemi‐Sadraei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6438-4192; OpenAlex author ID A5015231570. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer. First author DOI 10.1002/cam4.5133↗
  2. Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancrea… Co-author DOI 10.1097/coc.0000000000000409↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Olumide B. Gbolahan · 2 shared papers, 2018–2023 · strength 0.27
  2. Lisle Nabell · 1 shared paper, 2023 · strength 0.18
  3. Ravi Kumar Paluri · 1 shared paper, 2023 · strength 0.18
  4. Bassel F. El‐Rayes · 1 shared paper, 2023 · strength 0.18
  5. Hai Salfity · 1 shared paper, 2018 · strength 0.10
  6. Safi Shahda · 1 shared paper, 2018 · strength 0.10
  7. Bert H. O’Neil · 1 shared paper, 2018 · strength 0.10
  8. Michael Garrett House · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.